Navigation Links
Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 First Quarter Results
Date:5/3/2011

oking statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information.  All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to successfully conduct clinical development of LX1031, LX1032, LX1033, LX2931, and LX4211 and preclinical and clinical development of its other potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements.  Unless specifically indicated otherwise, results reported as trends were not statistically significant. Information identifying such important factors is contained under "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2010, as filed with the Securities and Exchange Commission.  Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.Lexicon Pharmaceuticals, Inc.Selected Financial DataConsolidated Statements of Operations DataThree Months EndedMarch 31,(In thousands, except per share data)20112010(unaudited)Revenues:Collaborative research$  516$  1,641Subscription and license fees80-Total revenues5961,641Operating expenses:Research and development, inclu
'/>"/>
SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Lexicon to Provide First Quarter 2011 Financial Results
2. Lexicon Pharmaceuticals Appoints Dr. Pablo Lapuerta Chief Medical Officer
3. Lexicon Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
4. Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2010 Fourth Quarter and Full Year Financial Results
5. Lexicon to Report Fourth Quarter and Year End 2010 Financial Results on February 24, 2011
6. Lexicon Announces Positive Results from New Clinical Study of LX4211 in Type 2 Diabetes Patients
7. Lexicon Pharmaceuticals to Present at the 29th Annual JPMorgan Healthcare Conference
8. Lexicon Announces Top-Line Phase 2a Data for LX2931 in Patients with Rheumatoid Arthritis
9. Lexicon to Provide Clinical Pipeline Update and Report Third Quarter 2010 Financial Results
10. Lexicon Pharmaceuticals to Present at BioCentury Newsmakers in the Biotech Industry Conference Oct. 22nd
11. Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... , Dec. 18, 2014 Somewhere between dropping ... health was forgotten. But Audicus , a next-generation ... better this new year. Hearing loss is ... aging population, though it is often unaddressed. Forty-eight million ... has a hearing aid, mainly due to price. Hearing ...
(Date:12/19/2014)... 18, 2014  Sage Analytics ( www.sageanalytics.com ), ... for the testing of marijuana potency and moisture ... Luminary™ Profiler, the industry,s first product suite capable ... cost-effective, portable unit. Designed from the ... the cannabis industry, the Luminary™ Profiler utilizes specially ...
(Date:12/19/2014)... Dec. 18, 2014 Capnia, Inc. (NASDAQ: ... of medical diagnostics based on its proprietary Sensalyze™ ... today announced financial results for the third quarter ... "Following the completion of our initial public ... maximize the recently initiated CoSense® commercial launch," said ...
Breaking Medicine Technology:Audicus Will Help People Resolve to Hear Better in 2015 2Sage Analytics Develops Breakthrough System for Potency Testing of Cannabis Products 2Capnia Reports Third Quarter 2014 Financial Results 2Capnia Reports Third Quarter 2014 Financial Results 3Capnia Reports Third Quarter 2014 Financial Results 4Capnia Reports Third Quarter 2014 Financial Results 5Capnia Reports Third Quarter 2014 Financial Results 6Capnia Reports Third Quarter 2014 Financial Results 7Capnia Reports Third Quarter 2014 Financial Results 8
... Jan. 6, 2011 /PRNewswire-Asia-FirstCall/ -- Nutrastar International Inc. (OTC ... "Company"), a leading producer and supplier of premium branded ... the Company will be participating in the upcoming Cowen ... the Westin New York at Times Square (270 West ...
... 2011 Viveve, Inc. , a development stage ... the European CE (Conformite Europeenne) mark for the use ... laxity of the vaginal introitus (opening), after childbirth, to ... ) "The CE mark is a key ...
Cached Medicine Technology:Nutrastar to Present at the Cowen and Company 9th Annual Consumer Conference in NYC 2Nutrastar to Present at the Cowen and Company 9th Annual Consumer Conference in NYC 3Viveve Obtains CE Mark for Gynecologic Treatment of Vaginal Laxity 2
(Date:12/19/2014)... drug users who also use cocaine and amphetamines have ... users, a new study finds. "We know that ... attempt and completed suicide," Didier Jutras-Aswad, a psychiatry professor ... news release. "However, there are many different profiles of ... users were actually more likely to attempt suicide." ...
(Date:12/19/2014)... Dec. 19, 2014 (HealthDay News) -- The cost of ... well-being, a new study finds. Researchers examined data ... been diagnosed with colorectal or lung cancer. Of those ... cancer-free, and more than 100 had advanced cancer. ... to pay their medical bills, which was linked with ...
(Date:12/19/2014)... NC (PRWEB) December 19, 2014 Surviving Mesothelioma ... and EPA information indicates that these pipes can leach asbestos ... go to the full story on the Surviving Mesothelioma ... the erosion of natural asbestos deposits, decaying water mains made ... drinking water. , To protect consumers from mesothelioma ...
(Date:12/19/2014)... Dennis Thompson HealthDay ... -- Ebola,s entrance into the United States -- along ... mumps outbreak -- have highlighted cracks in the nation,s ... new health policy report released Thursday. Half of ... respond to infectious disease outbreaks. That was the main ...
(Date:12/19/2014)... B. E. Smith, the only full-service leadership ... retained to lead a national chief financial officer ... The top executive search firm in the healthcare industry, ... healthcare executives into organizations. , Johnson Memorial Hospital ... to the residents of Johnson County and the surrounding ...
Breaking Medicine News(10 mins):Health News:Cocaine, Amphetamines May Up Injection Drug Users' Suicide Risk 2Health News:Cancer Treatment Costs Weigh Heavily on Patients, Study Finds 2Health News:Surviving Mesothelioma Warns of Potential Mesothelioma Risk from Cement Water Pipes 2Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 2Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 3Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 4Health News:Johnson Memorial Hospital Retains B. E. Smith to Recruit New Chief Financial Officer 2Health News:Johnson Memorial Hospital Retains B. E. Smith to Recruit New Chief Financial Officer 3
... benefits which could run parallel to that of penicillin ... of Medicine at Harvard Medical School. ,Professor ... levels in unrefined cocoa has the potential to combat ... world viz. stroke, heart ailments, cancer and diabetes. He ...
... German scientists have found that the scent of ... The scientists at the University of Lubeck, ... programmed bursts of rose odors, while they were memorizing cards ... sent off to sleep with electrodes connected to their heads. ...
... Hopkins emergency medicine specialists have developed a tool ... potential to overwhelm services//. ,The Electronic Mass ... calculates the impact of such crises as a ... accounting for such elements as numbers of victims, ...
... including those with a family history of the disease, should ... to prevent the disease. ,This is the first ... taking medicines to prevent colorectal cancer. After reviewing the latest ... potential harms of taking more than 300 mg per day ...
... who devote more time to physical activity have a ... next 15 years, according to new research// . ... physical activity is actually causally related to hypertension,” said ... an epidemiologist at the University of Minnesota in Minneapolis, ...
... conducted on mice shows that more copper in everyday ... was conducted by scientists at the University of Louisville ... ,Their studies show that giving copper supplements ... by preventing heart enlargement. The study will be published ...
Cached Medicine News:Health News:Scent of a Rose may Give More Than Pleasure 2Health News:Aspirin Or NSAIDs Will not Prevent Colorectal Cancer 2Health News:Physical Activity Reduces Hypertension Risk in Young Adults 2
Gentle-Flo® Vactrol® Connector., ,Indications For Usage: ,Removal of secretions from respiratory tract....
... 8 Suction Catheters With Contro-Vac Valve and ... Low-Risk Respiratory Suctioning, ,Medline's 6 and ... DeLee Tips are the optimal tools for ... a forward placed suction valve to minimize ...
... available in two tip styles- ... with staggered eyes, and the ... of catheter valve options, SAFE-T-VAC ... control with virtually no residual ...
... Our Tri-Flo® suction catheter design ... to your patients while still providing ... pediatric catheters (5/6, 8 or 10 ... facilitate proper catheter placement. Our complete ...
Medicine Products: